Brief: Shanghai Microport Medbot Says Transperineal Prostate Biopsy System Obtained Approval
May 18 (Reuters) - Shanghai MicroPort MedBot Group
2252.HK :
* ISR'OBOT MONA LISA ROBOTIC TRANSPERINEAL PROSTATE BIOPSY
SYSTEM
OBTAINED APPROVAL
* APPROVAL GIVEN BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION
OF
CHINA
Further company coverage: 2252.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai MicroPort MedBot (Group)
See all newsBrief: Shanghai Microport Medbot (Group) Says Yu Liu Resigns As Executive Director
Shanghai MicroPort jumps on semi-annual profitability expectations
Brief: Shanghai Microport Medbot (Group)Expects HY Net Profit Of RMB28 Million–RMB40 Million
Shanghai MicroPort jumps on breakthrough in core product installation
Brief: Shanghai Microport Medbot (Group) Says Toumai Remote Laparoscopic Surgery Robot Obtains EU CE Mark